Sleep duration and breast cancer phenotype

Area of Science:

• Oncology
• Sleep Medicine
• Epidemiology

Background:

• Growing evidence links short sleep duration to increased cancer risk.
• The impact of sleep on specific tumor characteristics remains under-investigated.
• Understanding sleep's role in cancer progression is crucial for patient outcomes.

Purpose of the Study:

• To investigate the relationship between sleep duration and tumor phenotype in breast cancer patients.
• To specifically examine if sleep duration correlates with tumor grade, stage, and receptor status.
• To explore these associations in the context of menopausal status.

Main Methods:

• Cross-sectional study involving 972 breast cancer patients.
• Data collected on sleep duration and various tumor characteristics.
• Statistical analyses, including univariate and adjusted models, were performed.

Main Results:

• A modest inverse association was found between sleep duration and tumor grade (univariate P = 0.032).
• This association was more pronounced in postmenopausal women (univariate P = 0.018).
• After adjustments, the association remained significant only in postmenopausal women (P = 0.049), not in the overall sample (P = 0.052).
• No significant association was observed between sleep duration and cancer stage, ER, or HER2 status.

Conclusions:

• Short sleep duration is modestly associated with higher-grade breast cancer, particularly in postmenopausal women.
• Sleep duration does not appear to be significantly linked to cancer stage or key receptor statuses (ER, HER2).
• Further research is warranted to validate these findings and elucidate the underlying mechanisms.